We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2006 by University of California, Los Angeles.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00377221
First Posted: September 18, 2006
Last Update Posted: September 18, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
AIDS Research Alliance
Johns Hopkins Bloomberg School of Public Health
Information provided by:
University of California, Los Angeles
  Purpose
Observational, cross-sectional, single-visit study of 896 men and women in Los Angeles, CA and Baltimore, MD including a computer-assisted interview focusing on the behavioral repertoire surrounding RAI, symptoms, and health seeking behaviors and a multidimensional assessment of behaviors, anorectal examination, and testing for sexually transmitted infections (STIs).

Condition
Rectal Health Rectal Behaviors Anorectal Symptomatology

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Rectal Health, Behaviors and Microbicide Acceptability

Further study details as provided by University of California, Los Angeles:

Estimated Enrollment: 896
Study Start Date: September 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

Men and women are eligible who meet all of the following criteria:

  1. At least 18 years of age
  2. Willing to be tested for STIs including HIV
  3. Willing to undergo an anal exam
  4. Mentally competent to understand study procedures and give informed consent.
  5. For the NO-RAI groups:

    No RAI in the past year for the non-RAI men and women

  6. For the practicing RAI groups:

Males: report RAI in the past 30 days Females: report RAI in the past 12 months

Exclusion Criteria:

  1. Less than 18 years of age
  2. Unwilling to be tested for STIs (and HIV)
  3. Unwilling to undergo an anal exam
  4. Unwilling to complete study questionnaire
  5. Not mentally competent to understand study procedures and give informed consent.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00377221


Locations
United States, California
AIDS Research Alliance Recruiting
Los Angeles, California, United States, 90069
Contact: Michelle Vertucci, NP/PA    310-358-2429      
Principal Investigator: Stephen Brown, MD         
Principal Investigator: Marjan Hezareh, PhD         
United States, Maryland
Johns Hopkins University Recruiting
Baltimore, Maryland, United States, 21205
Contact: Yasmeen Long    410-502-5949    ylong@jhsph.edu   
Principal Investigator: John Hylton, PhD         
Sponsors and Collaborators
University of California, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)
AIDS Research Alliance
Johns Hopkins Bloomberg School of Public Health
Investigators
Principal Investigator: Pamina Gorbach, DrPH University of California, Los Angeles
Principal Investigator: Peter A Anton, MD University of California, Los Angeles
Principal Investigator: Ross Cranston, MD University of California, Los Angeles
  More Information

ClinicalTrials.gov Identifier: NCT00377221     History of Changes
Other Study ID Numbers: U19-AI060614:P3 Aim1
05-07-098
H.34.05.08.24
ARA010
First Submitted: September 14, 2006
First Posted: September 18, 2006
Last Update Posted: September 18, 2006
Last Verified: September 2006

Additional relevant MeSH terms:
Anti-Infective Agents